Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Oct 25, 2019
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding the most effective ways to treat chronic low back pain (cLBP) in Veterans. Many Veterans experience cLBP, which can significantly interfere with daily activities. The study will compare different treatment approaches, including online pain management programs, enhanced physical therapy that combines education with exercise, and other therapies like yoga and cognitive behavioral therapy. The goal is to see which treatment helps reduce pain and improve daily functioning the most over a three-month period.
To participate, Veterans need to have low back pain that has lasted for at least six months and affects their daily life. They must be 18 years or older, able to attend in-person sessions, and have stable internet access. Participants will first try one of the initial treatments and, if they still need help after that, they may be randomly assigned to one of the additional therapies. Throughout the study, they will be monitored for a year to see how well the treatments work over time. If you're a Veteran dealing with chronic low back pain, this study could offer you a chance to explore new treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- To be eligible to participate in this study, an individual must meet all the following criteria:
- • 1. Low back pain
- • 1. present for at least 6 months,
- • 2. present most days or everyday,
- • 3. interferes the most with activities considering all of the places where the patient experiences pain;
- • 2. Pain, Enjoyment, General Activity (PEG) score of 4 or greater;
- • 3. Veteran age 18 years or older, either sex, any racial or ethnic background;
- • 4. Able to comprehend and willing to sign the study informed consent form;
- • 5. Able to attend in-person treatment sessions;
- • 6. Anticipate continuing care at the enrolling VA for the period of the study;
- • 7. Stable access to the internet at home, work, or other location (e.g. mobile phone), and an email address.
- Exclusion Criteria:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- • 1. Currently enrolled in any other interventional study unless exempted by CSP;
- • 2. Acute or chronic illness that would prevent the Veteran from receiving study treatments offered (e.g., uncontrolled hypertension, recent myocardial infarction within the last 6 months, unstable angina, acute congestive heart failure);
- • 3. Neurological impairment related to disease of the spine or other causes preventing participation in any of the treatment modalities under study;
- • 4. Current or recent (last 3 months) treatment involving Cognitive Behavioral Therapy, Spinal manipulation therapy, or Yoga;
- • 5. Current severe alcohol or substance abuse use disorder;
- • 6. Severe psychiatric illness (e.g. current psychosis, current suicidal ideation, or psychiatric illness requiring hospitalization within the last 6 months);
- • 7. Undergoing evaluation for back surgery or planned back surgery;
- • 8. Cognitive or severe hearing or visual impairment preventing participation in treatment options or outcome measure assessments;
- • 9. Pregnancy;
- • 10. Refusal to provide written consent.
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Decatur, Georgia, United States
Baltimore, Maryland, United States
Palo Alto, California, United States
Long Beach, California, United States
Hampton, Virginia, United States
Boston, Massachusetts, United States
San Antonio, Texas, United States
Indianapolis, Indiana, United States
Portland, Oregon, United States
Phoenix, Arizona, United States
Nashville, Tennessee, United States
Loma Linda, California, United States
Saint Louis, Missouri, United States
Richmond, Virginia, United States
Salt Lake City, Utah, United States
Bay Pines, Florida, United States
Asheville, North Carolina, United States
Orlando, Florida, United States
Aurora, Colorado, United States
North Las Vegas, Nevada, United States
Boston, Massachusetts, United States
Portland, Oregon, United States
Bay Pines, Florida, United States
Saint Louis, Missouri, United States
Dallas, Texas, United States
Indianapolis, Indiana, United States
Palo Alto, California, United States
Asheville, North Carolina, United States
San Antonio, Texas, United States
Salt Lake City, Utah, United States
Richmond, Virginia, United States
Patients applied
Trial Officials
David J Clark, PhD MD
Study Chair
VA Palo Alto Health Care System, Palo Alto, CA
Matthew J. Bair, MD MS
Study Chair
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials